Insider Transactions in Q4 2018 at Eli Lilly & CO (LLY)
Insider Transaction List (Q4 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2018
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
89
+1.09%
|
$9,612
$108.36 P/Share
|
|
Dec 17
2018
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.08%
|
$5,400
$108.36 P/Share
|
|
Dec 17
2018
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.23%
|
$10,908
$108.36 P/Share
|
|
Dec 17
2018
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
126
+50.0%
|
$14,490
$115.81 P/Share
|
|
Dec 10
2018
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Open market or private sale
|
Indirect |
25,000
-17.74%
|
$2,825,000
$113.15 P/Share
|
|
Dec 04
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
15,500
-0.01%
|
$1,844,500
$119.0 P/Share
|
|
Dec 02
2018
|
Anne E. White EVP & Pres, Lilly Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
3,306
-19.33%
|
$390,108
$118.64 P/Share
|
|
Dec 02
2018
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+30.48%
|
-
|
|
Nov 29
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
185,000
-0.08%
|
$21,645,000
$117.65 P/Share
|
|
Nov 28
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
190,000
-0.16%
|
$21,850,000
$115.57 P/Share
|
|
Nov 19
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
195,000
-0.08%
|
$22,425,000
$115.3 P/Share
|
|
Nov 19
2018
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,605
+3.59%
|
$184,575
$115.81 P/Share
|
|
Nov 19
2018
|
Carolyn R Bertozzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+31.36%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Michael L Eskew Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+3.71%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,558
+2.47%
|
$179,170
$115.81 P/Share
|
|
Nov 19
2018
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+9.0%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,594
+16.44%
|
$183,310
$115.81 P/Share
|
|
Nov 19
2018
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+2.63%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+12.06%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Kathi P Seifert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+2.07%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+2.68%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+8.25%
|
$173,765
$115.81 P/Share
|
|
Nov 19
2018
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,511
+27.34%
|
$173,765
$115.81 P/Share
|
|
Nov 16
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
200,000
-0.17%
|
$22,600,000
$113.73 P/Share
|
|
Nov 13
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
2,460
-0.0%
|
$277,980
$113.41 P/Share
|
|
Nov 12
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
202,540
-0.09%
|
$22,887,020
$113.92 P/Share
|
|
Nov 03
2018
|
Johna Norton EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
1,366
-7.11%
|
$144,796
$106.75 P/Share
|
|
Nov 03
2018
|
Johna Norton EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
3,133
+14.01%
|
-
|
|
Oct 17
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
174,696
-0.15%
|
$19,740,648
$113.25 P/Share
|
|
Oct 15
2018
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.24%
|
$10,890
$110.62 P/Share
|
|
Oct 15
2018
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
49
+0.08%
|
$5,390
$110.62 P/Share
|
|
Oct 15
2018
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+1.32%
|
$9,570
$110.62 P/Share
|
|
Oct 09
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,672
-0.01%
|
$1,227,280
$115.91 P/Share
|
|
Oct 08
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
14,632
-0.01%
|
$1,682,680
$115.91 P/Share
|
|
Oct 04
2018
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
7,000
-13.4%
|
$798,000
$114.64 P/Share
|
|
Oct 04
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
116,038
-0.02%
|
$13,112,294
$113.68 P/Share
|
|
Oct 03
2018
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
78,962
-0.07%
|
$8,606,858
$109.0 P/Share
|